Home > Insider Trading > Filing (0000784199-17-000101)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
784199	Cryolife Inc	CRY	Surgical & Medical Instruments & Apparatus (3841)	592417093

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1112830	Ashley David Lee	Cryolife, Inc. 1655 Roberts Blvd, Nw Kennesaw GA 30144	Executive Vp, Coo & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-11-08	33,190	$5.12	324,339	No	4	M	Direct
Common Stock	Disposition	2017-11-08	33,190	$19.00	291,149	No	4	S	Direct
Common Stock	Acquisiton	2017-11-09	30,143	$5.12	321,292	No	4	M	Direct
Common Stock	Disposition	2017-11-09	30,143	$18.57	291,149	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2017-11-08	33,190	$19.00	33,190	$5.12
Common Stock	Stock Option (Right to Buy)	Disposition	2017-11-09	30,143	$18.57	30,143	$5.12

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
30,143	2012-02-23	2018-02-23	No	4	M	Direct
0	2012-02-23	2018-02-23	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,000	Indirect	Shares owned by Spouse
Common Stock	1,500	Indirect	Shares owned by minor children

Footnotes

Stock option vested 33 1/3% per year beginning on the first anniversary of the grant date (February 23, 2012).
Reflects weighted average price. Range was $18.95 to $19.10. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Reflects weighted average price. Range was $18.50 to $18.85. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.